Status:
COMPLETED
The Impact of Oligosaccharides and Bifidobacteria on the Intestinal Microflora of Premature Infants
Lead Sponsor:
University of California, Davis
Collaborating Sponsors:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
Fecal Microflora in the Formula Fed Premature Infant
Eligibility:
All Genders
Phase:
PHASE1
Brief Summary
The purpose of this study is to see whether dietary supplements can change the germs in the intestines of premature infants to be more like those of healthy breast fed term babies.
Detailed Description
To determine the optimum dose and optimum dietary supplement to promote a fecal microflora in the formula fed premature infant that is similar to that of the term breast fed infant (a predominance of ...
Eligibility Criteria
Inclusion
- Born in or transferred to UCDMC within the first two weeks of life. Birth weight less than 1500 grams. Gestational age less than 33 completed weeks. Exclusively formula fed.
Exclusion
- Gastrointestinal or cardiac anomalies.
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2015
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT00810160
Start Date
June 1 2009
End Date
November 1 2015
Last Update
July 13 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UC Davis Medical Center
Sacramento, California, United States, 95817